4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000044
Chief Executive Officer sold 15,319 shares at $12.19 ($186,803)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2025-04-11 | Sale 10b5-1 | −15,319 | $12.19 | $186,803 | 862,289 | D |
| Open-market sales · 15,319 sh · avg $12.19 · $186,803 | |||||||
Loading xslF345X05/wk-form4_1744763608.xml…